Journal of Medicinal Chemistry p. 904 - 910 (1985)
Update date:2022-09-26
Topics:
Efange, Simon M. N.
Alessi, Elaine M.
Shih, H. C.
Cheng, Yung-Chi
Bardos, Thomas J.
1-(2-Deoxy-β-D-ribofuranosyl)-5-bromo-2-pyrimidinone (BrPdR) and 1-(2-deoxy-β-D-ribofuranosyl)-5-iodo-2-pyrimidinone (IPdR) have been synthesized by condensation of the appropriate silylated bases 2a and 2b, respectively, with 3,5-bis-O-(p-chlorobenzoyl)-2-deoxy-α-D-ribofuranosyl chloride (8) in 1,2-dichloroethane, in the presence of SnCl4, followed by separation of the anomeric blocked nucleosides via column chromatography and subsequent deprotection with methanolic ammonia.Both BrPdR and IPdR exhibited significant antiherpes activities against various strains of HSV-1 and HSV-2, the latter compound (IPdR) showing the higher activity as well as the stronger binding to the virus-specific thimidine kinase.
View MoreContact:+86-511-88790000
Address:338 North Yushan Rd, Zhenjiang, Jiangsu 212016
Contact:+86 21 34123252
Address:14, 4580 Dushi, Shanghai, China
Shanghai HengXun Pharmaceutical Tech. Co., Ltd.
Contact:86-86-52730756
Address:Room 603, No. 240, Tianmuzhong Road, Zhabei, Shanghai, China
Contact:+1-416-493-6870
Address:Toronto, Canada
Shaanxi HuaTai Bio-fine chemical company Ltd
Contact:86-029-87862197
Address:No. 5, 3rd Floor, 29 Yanta North Road, Beilin Dist.
Doi:10.1021/jo00216a015
(1985)Doi:10.1246/bcsj.20100212
(2011)Doi:10.1055/s-1985-31107
(1985)Doi:10.1016/S0040-4039(00)98584-8
(1985)Doi:10.1002/ejic.201900110
(2019)Doi:10.1016/S0040-4039(00)98115-2
(1985)